Skip to main content

Table 2 weight and white blood cells changes of tumor-burdened mouse before and after treatment

From: Establishment of malignantly transformed dendritic cell line SU3-ihDCTC induced by Glioma stem cells and study on its sensitivity to resveratrol

Group

Body weight (\( \overline{\mathrm{x}} \)±S g)

Peripheral blood (WBC, \( \overline{\mathrm{x}} \) ±S,106)

IBW

FBW

FBW/IBW

pretreated

first week

second week

A

21.00 ± 2.64

24.28 ± 2.10

1.16

12.38 ± 3.39

12.73 ± 3.48

17.01 ± 8.20

B

21.58 ± 2.34

24.90 ± 1.91

1.15

9.28 ± 0.58

9.70 ± 3.67

8.61 ± 2.23

C

22.88 ± 2.90

20.03 ± 1.10

0.87

17.77 ± 2.51

14.84 ± 2.6

9.82 ± 2.56

D

23.35 ± 0.15

20.67 ± 2.65

0.89

7.26 ± 1.11

7.31 ± 0.21

7.01 ± 1.48

  1. IBW is the initial body weight; FBW is the final body weight; A is control group; B is Res treatment; C is Cis treatment; D is combined treatment
Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us